Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection

12 Jul 2023

Abstract excerpt

Abstract Understanding protective immunity to COVID-19 facilitates preparedness for future pandemics and combats new SARS-CoV-2 variants emerging in the human population. Neutralizing antibodies have been widely studied; however, on the basis of large-scale exome sequencing of protected versus severely ill patients with COVID-19, local cell-autonomous defence is also crucial 1–4 . Here we identify phospholipid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium signaling and nucleotide metabolism
Share to Complement system in diseases
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37438530
DOI: 10.1038/s41586-023-06322-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infectionPMID 37438530Read ↗

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistSemantic proximity Read ↗

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistSemantic proximity Read ↗

Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-lambdaR1) and IFN-lambda Signaling in Influenza A Virus (IAV) InfectionSemantic proximity Read ↗

Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS‐CoV‐2 entry into human cellsSemantic proximity Read ↗

Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoproteinSemantic proximity Read ↗

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitroSemantic proximity Read ↗

SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte eliminationSemantic proximity Read ↗

IFN-inducible Human Phospholipid Scramblase 1 (PLSCR1) Protein Restricts HIV-1 Infection by Inhibiting Membrane FusionSemantic proximity Read ↗

Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targetsSemantic proximity Read ↗

Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>Semantic proximity Read ↗

Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonistSemantic proximity Read ↗

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethalitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.